Comparison of Perioperative, Oncological, and Functional Outcomes of Three-Dimensional Versus Robot-Assisted Laparoscopic Radical Prostatectomy: A Preliminary Study.

Journal: Journal of laparoendoscopic & advanced surgical techniques. Part A
Published Date:

Abstract

Radical prostatectomy (RP) is the first-line treatment modality for prostate cancer and can be performed using retropubic or minimally invasive techniques. New technologies such as the da Vinci robotic system and three-dimensional (3D) laparoscopic imaging system have been developed to overcome the challenges of conventional laparoscopy. This study aimed to compare the perioperative, oncological, and functional outcomes of robot-assisted laparoscopic RP (RALP) and 3D laparoscopic RP (3D LRP). The study was approved by the local ethics committee and included 65 patients (38 RALP, 27 3D LRP) who underwent RP with the diagnosis of localized prostate cancer between May 2019 and January 2020. All demographic, clinical, perioperative, pathological, and postoperative variables were recorded. There was no statistically significant difference between the two groups in terms of preoperative patient characteristics. The mean operative times of the RALP and 3D LRP groups were 135.74 ± 11.51 and 165.37 ± 15.86 minutes, respectively, with a statistically significant difference between the two groups ( = .001). The mean estimated blood loss was 237 ± 71 mL in the RALP group and 257 ± 54 mL in the 3D LRP group, with no statistically significant difference between the two groups ( = .236). In the 6 months of follow-up, there was no statistically significant difference between the two groups in terms of biochemical recurrence, continence, and potency. RALP and 3D LRP have similar perioperative, short-term oncological and functional outcomes other than the operative time. There is a need for prospective, randomized studies with larger populations evaluating long-term oncological and functional outcomes.

Authors

  • Fatih Kursat Yilmazel
    Department of Urology and University of Health Sciences, Erzurum Regional Training and Research Hospital, Erzurum, Turkey.
  • Emre Sam
    Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Department of Urology, Istanbul.
  • Ahmet Emre Cinislioglu
    Department of Urology and University of Health Sciences, Erzurum Regional Training and Research Hospital, Erzurum, Turkey.
  • Ibrahim Hakki Tor
    Department of Anesthesiology and Reanimation, University of Health Sciences, Erzurum Regional Training and Research Hospital, Erzurum, Turkey.
  • Fatih Akkas
    Department of Urology and University of Health Sciences, Erzurum Regional Training and Research Hospital, Erzurum, Turkey.
  • Fevzi Bedir
    Department of Urology and University of Health Sciences, Erzurum Regional Training and Research Hospital, Erzurum, Turkey.
  • Ibrahim Karabulut
    Department of Urology and University of Health Sciences, Erzurum Regional Training and Research Hospital, Erzurum, Turkey.
  • Hasan Riza Aydin
    Department of Urology, University of Health Sciences, Trabzon Kanuni Training and Research Hospital, Trabzon, Turkey.
  • Senol Adanur
    Department of Urology, Ataturk University Faculty of Medicine, Erzurum, Turkey.
  • Ozkan Polat
    Department of Urology, Ataturk University Faculty of Medicine, Erzurum, Turkey.